Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

Neurology

Volumn 59, Issue 11, 2002, Pages 1730-1734

  Carpio, Arturo ^a,b   Hauser, W Allen ^a,b,c  

^a UNIVERSIDAD DE CUENCA   (Ecuador)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; SEIZURE; SEX DIFFERENCE;

EID: 0037058768     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000036320.69823.EA     Document Type: Article

References (28)

1. Carpio A, Escobar A, Hauser WA. Epilepsy and cysticercosis: A critical review. Epilepsia 1998;39:1025-1040.
2. Pal DK, Carpio A, Sander JWAS. Neurocysticercosis and epilepsy. J Neurol Neurosurg Psychiatry 2000;68:137-143.
3. Manreza ML. Neurocysticercosis in children. In: Fejerman N, Chamoles NAN, eds. Trends in Pediatric Neurology. Amsterdam: Elsevier Science, 1993:295-298.
4. Caplan LR, EstaÑol B, Mitchel WG, Loyo-Varela M. How to manage patients with neurocysticercosis. Eur Neurol 1997;37:124-131.
5. Monteiro L, Nuñes B, Mendonaca D, Lopes J. Spectrum of epilepsy in neurocysticercosis: A long-term follow-up of 143 patients. Acta Neurol Scand 1995;92:33-40.
6. Mitchell WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: Diagnosis and treatment. Pediatrics 1988; 82:76-82.
7. Medina MT, Genton P, Montoya MC, Cordova S, Dravet C, Sotelo J. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: A pilot trial. Epilepsia 1993;34: 1024-1027.
8. Vázquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
9. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-445.
10. Commission on Epidemiology and Prognosis of the International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34:592-596.
11. Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of seizures. Epilepsia 1981;22:489-501.
12. Carpio A, Placencia M, Santillán F, Escobar A. Proposal for a new classification of neurocysticercosis. Can J Neurol Sci 1994;21:43-47.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
15. Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990; 323:497-502.
16. Garg RK, Singh MK, Misra S. Single-enhancing CT lesions in Indian patients with seizures: A review. Epilepsy Res 2000;38:91-104.
17. Murthy JM, Reddy VS. Prognosis of epilepsy associated with single CT enhancing lesion: A long term follow up study. J Neurol Sci 1998;159:151-155.
18. So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorder after cerebral infarction. Neurology 1996;46:350-355.
19. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: The Oxfordshire Community Stroke Project. Br Med J 1997;315:1582-1587.
20. Reith J, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Seizures in acute stroke: Predictors and prognostic significance. Stroke 1997;28:1585-1589.
21. Salazar AM, Jabbari B, Vance SC, et al. Epilepsy after penetrating head injury. I. Clinical correlates: A report of the Vietnam Head Injury Study. Neurology 1985;35:1406-1414.
22. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology 1988;38:1407-1410.
23. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998;338:20-24.
24. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizures after acute symptomatic seizure: Effect of status epilepticus. Ann Neurol 1998; 44:908-912.
25. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998;338:429-434.
26. Shinnar S, Berg AT, O'Dell C, Newstein D, Moshe SL, Hauser WA. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 2000;48:140-147.
27. Padma MV, Behari M, Misra NK, Ahuja NK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:1344-1346.
28. Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982-1988.